Patheon® is a leading provider of drug substance and drug product services for the global biopharmaceutical industry. SEE AND Read More »

Want to learn more?

Patheon Overview Brochure

Gelcaps – Only from Patheon

Embraced by the industry and preferred by three out of four patients, gelcaps are proven by many successful OTC products. This patented technology enrobes tablets with either traditional gelatin or non-animal gelatin film in a broad palette of colors and two-tone combinations.

Preferred by Three Out of Four Patients

  • Safely encases highly potent compounds
  • Traditional gelatin or EcoCaps™ non-animal gelatin formulations
  • Mitigates risk of tampering or counterfeiting
  •    

    Stand Out with Multiple Appearance Options

    • Wide selection of colors and two-tone combinations
    • Easily imprinted
    • Perfect for clinical trial blinding

Ask The Experts

Anil Kane, Ph.D., MBA

Anil Kane, Ph.D., MBA
Dr. Kane has more than 25 years of experience in the science and business of taking molecules throug
Read More »

Kaspar van den Dries, Ph.D.

Kaspar van den Dries, Ph.D.
Based at our Tilburg facility in the Netherlands, Dr. van den Dries leads Patheon’s European researc
Read More »

Jason Vaughn, Ph.D.

Jason Vaughn, Ph.D.
Dr. Vaughn has expertise in early and preclinical development of liquid, semi-solid and solid dosage
Read More »

Roman Hlodan, Ph.D.

Roman Hlodan, Ph.D.
Dr. Hlodan is an expert in the development of biopharmaceuticals, including analytical method devel
Read More »

Stephen Closs

Stephen Closs
Mr. Closs possess more than 23 years of experience in formulation development, tech transfer, scale-
Read More »

William E. Weiser, Ph.D.

William E. Weiser, Ph.D.
Dr. Weiser is an expert in analytical method development and validation for APIs and drug products.
Read More »

View All »

Knowledge Library


Please fill the below form to access requested content

First Name

Last Name

Company

Title

Email

Phone

Address Line 1

Address Line 2

City

Zip/ Postal Code

Country

Submit